| Use |
[Drug Name]
Common name: Azelastine Hydrochloride Nasal Spray
Chinese pinyin: Yansuandanzhuositing bifenwuji
[ingredients] Azelastine hydrochloride.
[Properties] This product is a colorless transparent liquid, high pressure valve, medicine is sprayed in a mist.
[indications] seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis
[dosage] 1 spray/nostril, morning and evening, twice daily (equivalent to a 0, 56mg Azelastine hydrochloride dose per day) or as described. When spraying, keep the head upright before the symptoms disappear should adhere to the use of acerbine nasal spray, but continuous use is not more than 6 months.
[adverse reactions] a small number of patients spray will produce nasal mucosa irritation, individual patients appear epistaxis. If the method of administration is incorrect, there will be bitter taste.
[medication for pregnant and lactating women] Although the drug test in large doses in animals did not produce a malformed response to the drug, however, the drug is not recommended for women in the first 3 months of pregnancy. The use of this product is strictly prohibited for lactating mothers.
[children's medication] children over 6 years old with adult dosage
[drug interaction] found no interaction with other drugs.
[overdose] animal tests have shown that excessive oral doses can cause symptoms of the central nervous system, once this situation occurs, it should be symptomatic treatment or supportive therapy, no specific antidote.
[Pharmacology and Toxicology] Azelastine hydrochloride is a new structure of 2, 3 diazepinone derivatives, as a potential long-acting anti-allergic compounds, with H1 receptor antagonist characteristics. Animal experimental data show that high concentrations of Azelastine hydrochloride can prevent the synthesis and release of certain chemical mediators (eg, leukotrienes, histamine, serotonin) in allergic reactions. And can prevent the migration of I-CAMI of the upregulated and eosinophilic cells to exert a wide range of anti-inflammatory effects. No local or organ-specific toxic reactions were detected at the maximum dose permitted for nasal spray administration.
[pharmacokinetics] repeated daily nasal spray of 0, 56mg Azelastine hydrochloride (equivalent to 1 spray/nostril, 2 times/day), the steady-state plasma concentration of Azelastine hydrochloride Cmax in healthy volunteers was 0, 27ng/ml, its active metabolite, N-Desmethyl azelastine, can be detected at or below the limit of quantification (0, 12ng/ml).
[storage] sealed and kept in a cool place.
[validity period] tentative 18 months |
